These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19740130)

  • 21. Inter-state disparities in health care and financial burden on the poor in India.
    Purohit BC
    J Health Soc Policy; 2004; 18(3):37-60. PubMed ID: 15201118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New estimates of elasticity of demand for healthcare in rural China.
    Zhou Z; Su Y; Gao J; Xu L; Zhang Y
    Health Policy; 2011 Dec; 103(2-3):255-65. PubMed ID: 22014842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accounting for costs, QALYs, and capacity constraints: using discrete-event simulation to evaluate alternative service delivery and organizational scenarios for hospital-based glaucoma services.
    Crane GJ; Kymes SM; Hiller JE; Casson R; Martin A; Karnon JD
    Med Decis Making; 2013 Nov; 33(8):986-97. PubMed ID: 23515216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of monitoring glaucoma patients in shared care: an economic evaluation alongside a randomized controlled trial.
    Holtzer-Goor KM; van Sprundel E; Lemij HG; Plochg T; Klazinga NS; Koopmanschap MA
    BMC Health Serv Res; 2010 Nov; 10():312. PubMed ID: 21083880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Pyhäjärvi Cataract Study. I. Study design, baseline characteristics and the demand for cataract surgery.
    Falck A; Kuoppala J; Winblad I; Tuulonen A
    Acta Ophthalmol; 2008 Sep; 86(6):648-54. PubMed ID: 18093260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost of close the gap for vision of Indigenous Australians: On estimating the extra resources required.
    Hsueh YS; Brando A; Dunt D; Anjou MD; Boudville A; Taylor H
    Aust J Rural Health; 2013 Dec; 21(6):329-35. PubMed ID: 24299438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of expanded mental health benefits on treatment costs.
    Sasso AT; Lurie IZ; Lee JU; Lindrooth RC
    J Ment Health Policy Econ; 2006 Mar; 9(1):25-33. PubMed ID: 16733269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in use and costs of primary health and social services in mental health or drinking problems.
    Forma L; Jarvala T; Ahonen J; Vitikainen K; Rissanen P
    J Ment Health Policy Econ; 2009 Jun; 12(2):79-86. PubMed ID: 19567933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Increase in the demand for eye-care services in the Netherlands 2010-2020].
    Keunen JE; Verezen CA; Imhof SM; van Rens GH; Asselbergs MB; Limburg JJ
    Ned Tijdschr Geneeskd; 2011; 155(41):A3461. PubMed ID: 22008156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of benefits and costs of an ophthalmic outreach clinic in general practice.
    Gillam SJ; Ball M; Prasad M; Dunne H; Cohen S; Vafidis G
    Br J Gen Pract; 1995 Dec; 45(401):649-52. PubMed ID: 8745862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addressing health care market reform through an insurance exchange: essential policy components, the public plan option, and other issues to consider.
    Fronstin P; Ross MN
    EBRI Issue Brief; 2009 Jun; (330):1-22. PubMed ID: 19545086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
    Cecil WT; Barnes J; Shea T; Coulter SL
    J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of in-office waiting time on physician visit frequency among working-age adults.
    Tak HJ; Hougham GW; Ruhnke A; Ruhnke GW
    Soc Sci Med; 2014 Oct; 118():43-51. PubMed ID: 25089963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut--a secret-shopper survey.
    Patel VB; Nahar R; Murray B; Salner AL
    Conn Med; 2013 Apr; 77(4):197-203. PubMed ID: 23691732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health technology assessment: A primer for ophthalmology.
    Murphy A; McElnea E; Byrne S
    Eur J Ophthalmol; 2018 Jul; 28(4):358-364. PubMed ID: 29973070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive model for measuring real-life cost-effectiveness in eyecare: automation in care and evaluation of system (aces-rwm™).
    Tuulonen A; Kataja M; Aaltonen V; Kinnunen K; Moilanen J; Saarela V; Linna M; Malmivaara A; Uusitalo-Jarvinen H
    Acta Ophthalmol; 2022 May; 100(3):e833-e840. PubMed ID: 34263537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.